Response to Crizotinib after Entrectinib Resistance in ROS1 -Rearranged, MET -Amplified Lung Adenocarcinoma

Victor R. Vaz; Malini M. Gandhi; Biagio Ricciuti; Joao V. Alessi; Arielle Elkrief; Marc Ladanyi; Chad Vanderbilt; Federica Pecci; Mihaela Aldea; Adriana Barrichello; Arushi Saini; Lynette Sholl; Jacob M. Sands; Mark M. Awad

doi:10.1200/PO-24-00394

Response to Crizotinib after Entrectinib Resistance in ROS1 -Rearranged, MET -Amplified Lung Adenocarcinoma

Victor R. Vaz, Malini M. Gandhi, Biagio Ricciuti, Joao V. Alessi, Arielle Elkrief, Marc Ladanyi, Chad Vanderbilt, Federica Pecci, Mihaela Aldea, Adriana Barrichello, Arushi Saini, Lynette Sholl, Jacob M. Sands, Mark M. Awad

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

Résumé

Crizotinib successfully overcomes MET amplification in ROS1-rearranged NSCLC after entrectinib failure.

langue originale	Anglais
Numéro d'article	e2400394
journal	JCO Precision Oncology
Volume	8
Les DOIs	https://doi.org/10.1200/PO-24-00394
état	Publié - 1 oct. 2024
Modification externe	Oui

Accès au document

10.1200/PO-24-00394

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Vaz, V. R., Gandhi, M. M., Ricciuti, B., Alessi, J. V., Elkrief, A., Ladanyi, M., Vanderbilt, C., Pecci, F., Aldea, M., Barrichello, A., Saini, A., Sholl, L., Sands, J. M., & Awad, M. M. (2024). Response to Crizotinib after Entrectinib Resistance in ROS1 -Rearranged, MET -Amplified Lung Adenocarcinoma. JCO Precision Oncology, 8, Article e2400394. https://doi.org/10.1200/PO-24-00394

@article{fc41af2928aa482a803de0d41f4ec004,

title = "Response to Crizotinib after Entrectinib Resistance in ROS1 -Rearranged, MET -Amplified Lung Adenocarcinoma",

abstract = "Crizotinib successfully overcomes MET amplification in ROS1-rearranged NSCLC after entrectinib failure.",

author = "Vaz, {Victor R.} and Gandhi, {Malini M.} and Biagio Ricciuti and Alessi, {Joao V.} and Arielle Elkrief and Marc Ladanyi and Chad Vanderbilt and Federica Pecci and Mihaela Aldea and Adriana Barrichello and Arushi Saini and Lynette Sholl and Sands, {Jacob M.} and Awad, {Mark M.}",

note = "Publisher Copyright: {\textcopyright} 2024 by American Society of Clinical Oncology.",

year = "2024",

month = oct,

day = "1",

doi = "10.1200/PO-24-00394",

language = "English",

volume = "8",

journal = "JCO Precision Oncology",

issn = "2473-4284",

}

TY - JOUR

T1 - Response to Crizotinib after Entrectinib Resistance in ROS1 -Rearranged, MET -Amplified Lung Adenocarcinoma

AU - Vaz, Victor R.

AU - Gandhi, Malini M.

AU - Ricciuti, Biagio

AU - Alessi, Joao V.

AU - Elkrief, Arielle

AU - Ladanyi, Marc

AU - Vanderbilt, Chad

AU - Pecci, Federica

AU - Aldea, Mihaela

AU - Barrichello, Adriana

AU - Saini, Arushi

AU - Sholl, Lynette

AU - Sands, Jacob M.

AU - Awad, Mark M.

PY - 2024/10/1

Y1 - 2024/10/1

N2 - Crizotinib successfully overcomes MET amplification in ROS1-rearranged NSCLC after entrectinib failure.

AB - Crizotinib successfully overcomes MET amplification in ROS1-rearranged NSCLC after entrectinib failure.

UR - http://www.scopus.com/inward/record.url?scp=85206923264&partnerID=8YFLogxK

U2 - 10.1200/PO-24-00394

DO - 10.1200/PO-24-00394

M3 - Article

C2 - 39374479

AN - SCOPUS:85206923264

SN - 2473-4284

VL - 8

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2400394

ER -